📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Stemcentrx

1.1 - Company Overview

Stemcentrx Logo

Stemcentrx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of disease-specific cancer therapies that target tumors at their roots to cure and significantly improve survival for patients, offering pharmaceutical services. Operates as a subsidiary of AbbVie.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Stemcentrx

Immix Biopharma Logo

Immix Biopharma

HQ: United States Website
  • Description: Provider of oncology and inflammation-driven therapeutics and platforms, including NXC-201, a BCMA-targeted CAR-T in Phase 1b/2a for relapsed/refractory AL amyloidosis and multiple myeloma, and IMX-110, a tissue-specific therapy in Phase 1b/2a for advanced solid tumors. Develops the N-GENIUS Cell Therapy Platform (EXPAND) and SMARxT platform, plus TME and Immune Normalization technologies to enhance CAR-T and address pathologic inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immix Biopharma company profile →
Haystack Oncology Logo

Haystack Oncology

HQ: United States Website
  • Description: Provider of tumor-informed liquid biopsy and ctDNA detection solutions to diagnose minimum residual disease and inform therapy decisions, including Haystack MRD to detect residual/recurrent/resistant disease; Haystack Duo Chemistry for sensitive detection of low-abundance mutant DNA; and clinical trial collaborations to evaluate therapeutic response.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Haystack Oncology company profile →
Adaptimmune Logo

Adaptimmune

HQ: United Kingdom Website
  • Description: Provider of T-cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases, including afami-cel, a single-dose T-cell therapy targeting cancer, and lete-cel, a single-dose T-cell therapy in development for treating solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adaptimmune company profile →
Vaxess Logo

Vaxess

HQ: United States Website
  • Description: Provider of needle-free vaccine and therapeutic delivery solutions, offering the MIMIX applicator with patch for skin-based administration and silk fibroin biomaterials that create stable, biocompatible delivery systems, with a focus on improving access to vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vaxess company profile →
Mariana Oncology Logo

Mariana Oncology

HQ: United States Website
  • Description: Provider of precision radiopharmaceuticals and radioligand therapeutics for solid tumors, including MC-339 for small cell lung cancer with an actinium-based payload. Offers an integrated discovery and development platform covering target biology, ligand discovery, and optimization, and theranostic approaches using the same ligand for therapy and diagnosis to confirm target engagement, guide patient selection, and optimize dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mariana Oncology company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Stemcentrx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Stemcentrx

2.2 - Growth funds investing in similar companies to Stemcentrx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Stemcentrx

4.2 - Public trading comparable groups for Stemcentrx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Stemcentrx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Stemcentrx

What does Stemcentrx do?

Stemcentrx is a provider of disease-specific cancer therapies that target tumors at their roots to cure and significantly improve survival for patients, offering pharmaceutical services. Operates as a subsidiary of AbbVie.

Who are Stemcentrx's competitors?

Stemcentrx's competitors and similar companies include Immix Biopharma, Haystack Oncology, Adaptimmune, Vaxess, and Mariana Oncology.

Where is Stemcentrx headquartered?

Stemcentrx is headquartered in United States.

How many employees does Stemcentrx have?

Stemcentrx has 1,000 employees 🔒.

When was Stemcentrx founded?

Stemcentrx was founded in 2010 🔒.

What sector and industry vertical is Stemcentrx in?

Stemcentrx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Stemcentrx

Who are the top strategic acquirers in Stemcentrx's sector and industry

Top strategic M&A buyers and acquirers in Stemcentrx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Stemcentrx?

Top strategic M&A buyers groups and sectors for Stemcentrx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Stemcentrx's sector and industry vertical

Which are the top PE firms investing in Stemcentrx's sector and industry vertical?

Top PE firms investing in Stemcentrx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Stemcentrx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Stemcentrx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Stemcentrx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Stemcentrx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Stemcentrx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Stemcentrx?

The key public trading comparables and valuation benchmarks for Stemcentrx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Stemcentrx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Stemcentrx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Stemcentrx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Stemcentrx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Stemcentrx's' sector and industry vertical?

Access recent funding rounds and capital raises in Stemcentrx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Stemcentrx